SpecGx














Didn’t you hear? Aurobindo dropped their bid earlier in the week. Intas was never really serious about their offer. Nobody wants to buy this POS division. Expect a shutdown in a year or two, and all the plants will be sold for pennies on the dollar.
 






Didn’t you hear? Aurobindo dropped their bid earlier in the week. Intas was never really serious about their offer. Nobody wants to buy this POS division. Expect a shutdown in a year or two, and all the plants will be sold for pennies on the dollar.

Not if they can use assets for next best thing: Weed.
 






You may be right. Colorado makes more money on weed than Mallinckrodt will ever make on drugs.I dont bother to tell people where i work anymore,it's not a point of pride anymore.
 






























So,Aurobindo bought Novartis generics. They strung Mallinckrodt along like a fish on a line, and then just cut them loose. Funny!

Mallinckrodt gets jilted again. Nobody wants to buy SpecGX. Maybe they’ll wind down Generics in 2019 to avoid any liability lawsuits. API will then be prepped for a sale once Generics closes shop.
 
















































What's next Mark ? Back to continued operations ? Spinoff ? Run it into the ground until nothing is left ?

Let’s not lose sight, this is the big question. The “bookkeeping” maneuver to count SpecGX as discontinued operations was too clever by half. Now it comes back to bite them in the butt.

My prediction: Generics will be discontinued sometime next year. API remains but will be put on the market.
 






exactly. Let’s “discontinue” this business to juice our YOY and QOQ numbers but also think someone will pay us top dollar for a “discontinued” business. Asinine!!!